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Prognostic value of ACEF (age, creatinine, ejection fraction) score of one year
mortality in 30-day survivors undergoing percutaneous coronary intervention
after acute myocardial infarction
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Background: Predictors of one year mortality in 30-day survivors after acute
myocardial infarction (AMI) has not been elucidated yet. Recently, several studies
reported that ACEF (age, creatinine, ejection fraction) score could provide a prog-
nostic information in patients undergoing percutaneous coronary intervention (PCI)
after AMI. Accordingly, the aim of this study is to assess whether ACEF score could
predict one year mortality in 30-day post-MI survivors.
Methods: Between November 2005 and August 2011, 12,000 30-day post-MI
survivors (8760 men; mean age ¼ 62.212.4 year-old) underwent PCI were analyzed
in this study from Korea AMI registry. ACEF score was calculated on the basis of the
modiﬁed formula; [age/left ventricular ejection fraction] + 1 if serum creatinine
>2mg/dL. Patients were categorized into 3 groups according to tertiles of ACEF
score; ACEF_low (<1.0, n¼3,755), ACEF_mid (1.0-1.39, n¼4,470), and ACEF_high
(1.4, n¼3,775).
Results: During the follow-up, ACEF score was signiﬁcantly higher in 30-day
post-MI survivors with 12-month mortality (1.285.04 versus 1.950.82, p
<0.001). In Cox proportional hazards model, ACEF score (hazards ratio [HR]
2.26, 95% conﬁdence interval [CI] 2.03 – 2.51; p <0.001) was an independent
predictor of 12-month mortality after adjusting for conventional clinical risk
factors. In receiver operating characteristics curves, area under the curve (AUC) of
ACEF score for predicting 12-month mortality was 0.788 (sensitivity 71.2% and
speciﬁcity 74.4%), and optimum cut-off value was 1.47. Kaplan-Meier survival
curve showed the patients with ACEF score of 1.47 or more (6.9% versus 1.0%;
log-rank p <0.001) had signiﬁcantly higher 12-month mortality compared with
patients with ACEF score <1.47. The 12-month mortality was 0.4% in ACE-
F_low, 1.4% in ACEF_mid, and 6.1% in ACEF_high, respectively (p<0.001).
Adjusted HRs for 12-month mortality were 1 (reference), 3.11 (95%CI 1.70 - 5.70;
p<0.001), and 10.38 (95%CI 5.83 – 18.47; p<0.001), respectively.
Conclusions: The ACEF score provides useful prognostic information for clinicians
to advise patients who have survived the acute phase of AMI. More intensive
management is required in post-MI survivors with high ACEF score.TCT-253
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ST-Elevation Myocardial Infarction (STEMI)
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Background: Since consistent rapid door-to-balloon (D2B) times have largely been
solved in most PCI hospitals, reduction in total ischemia time (RITIT) from symptom
onset to less than 120-180 minutes to reperfusion has been proposed as a better goal
(rather than ﬁrst medical contact) to reduce mortality in regional systems of STEMI
care. Therefore we sought key drivers of RITIT in our combined metro and regional
STEMI system.
Methods: Treatment times from January 2011-March 2013 representing direct (non-
transfer) and transfer patients for PCI reperfusion for STEMI from a 9 hospital metro
and regional system serving over 2 million were collected and a multivariable analysis
of gender, age, race, off hours onset of pain, and method of initial transport was
performed.
Results: A total of 197 patients were direct STEMI patients with 168 arriving by
emergency medical services (EMS) and 75% having onset of pain to reperfusion
in <¼ 180 minutes, while 29 came by privately operated vehicle (POV) with
52% within 180 minutes (p¼0.01). A total of 195 patients were transfer STEMI
with 56 arriving at the referral hospital by EMS and 139 arriving by POV with
75% EMS having total ischemia time <¼ 180 minutes versus 57% POV
(p¼0.02). Details of mean time interval differences for both groups are shown in
the graph below:JACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT AbstrConclusions: Only the method of arrival to the initial hospital was signiﬁcant in
multivariable models of total ischemia time. In both metro and regional settings,
calling 911 for EMS is the key determinant for subsequent RITIT in STEMI and leads
to time reduction in every step to reperfusion.
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Background: No data are currently available on the use of everolimus eluting bio-
resorbable vascular scaffolds (BVS) in patients presenting with ST-segment elevation
myocardial infarction (STEMI).
Methods: The present report is a prospective, single arm, single centre study evalu-
ating the safety, feasibility and performance of BVS for treatment of consecutive
patients presenting with STEMI. Baseline quantitative coronary angiography and post-
implantation optical coherence tomography (OCT) data were evaluated. Clinical
outcomes are reported at 30-day follow-up.
Results: The intent-to-treat population comprises a total of 40 patients. The procedural
success was 97.5% (39/40 patients). Mean door-to-needle time was 30.33 18.51 min.
Male gender was present in 31 patients (77.5%). Mean age was 57.99.8 years. Pre-
procedure TIMI ﬂow was 0 in 52.6% of the patients; Thrombectomy was performed in
31 patients (79.5%), and additional balloon pre-dilatation in 22 subjects (56.5%). After
BVS implantation a TIMI ﬂow III was achieved in 35 patients (89.7%), no reﬂow was
observed in 1 case (2.6%), and distal embolization in 7 cases (17.9%). The post-
procedure %diameter stenosis was 15.3  8.2%. MI SYNTAX score I and II were
respectively 10.5 (7.5-15.0) and 8.0 (5.0-13.0). OCT analysis was performed in a total of
25 patients. The mean lumen area was 7.761.88 mm2, minimum lumen area
5.611.48 mm2, minimum ﬂow area 5.291.54 mm2, mean incomplete stent appo-
sition area 0.1310.179 mm2, mean prolapse area 0.580.28 mm2, mean intraluminal
material area 0.0130.017 mm2; mean %malapposed struts 2.804.11%, scaffolds
with >5% malapposed struts were 5. At 30-days follow-up the MACE rate was 2.6%,
this was due to a non-target vessel Non Q-Wave myocardial infarction (MI), Target
vessel failure rate was 0%. No target vessel revascularisation, and target vessel MI were
reported. No cases of cardiac death or scaffold thrombosis were observed.
Conclusions: The use of BVS in patients presenting with acute myocardial infarction
was observed to be safe and feasible. Angiographic and OCT data showed optimal
acute results with high rate of TIMI III ﬂow, low residual stenosis and good apposition
of the scaffold.
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Background: Coronary angiogram (CA) with percutaneous coronary intervention
(PCI) on admission may improve survival to hospital discharge in out-of-hospitalacts/POSTER/STEMI/NSTEMI/ACS B83
